A federal advisory committee voted overwhelmingly against the authorization of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, expressing concerns about the integrity of the particular trials up for review despite the treatment’s potential to transform a field with significant need. What do you think?
“The FDA had a different opinion at the club last night.”
Salvatore Zimbaro • Drum Technician
“What’s the point of having PTSD then?”
Debbie Favari • Shrub Specialist
Advertisement
“I find talk therapy to be just as euphoric!”
Nolan Reyes • Bolt Inspector